Scientific Program

Scientific Program

The latest updates by world-renowned experts in the field of diabetes

We are planning an innovative and exciting program for ATTD 2021. The full program will be available shortly.

Review the initial session topics and speakers below.

*Updated 2 July 2020

First NameLast NameCountryTopic
KatharineBarnardUKPatient Related Outcomes (PROs) – presentation of key instruments and how to use them (INSPIRE measures)
BruceBuckinghamUSAA pivotal trial of Omnipod Horizon™ Automated Glucose Control System
FergusCameronAustraliaDebate: In the era of remote visits – do we still need A1c measures

Stuart Weinzimer – CON

Fergus Cameron – PRO

AntonioCerielloItalyHow to manage type 2 diabetes and obesity during the COVID-19 pandemic
MarkClementsUSAWhat do we need to develop/improve with the technology that we are using today
ChristopheDe BlockBelgiumNAFLD/NASH in type 1 diabetes
KlemenDovcSloveniaFaster acting insulin analogues in closed-loop insulin delivery
FrancisDoyle IIIUSAUpdate on Artificial Pancreas engineering and clinical studies
StevenEdelmanUSAStrategies for improvement of metabolic control in adults with T1D
DeniceFeigCanadaDEBATE: Should all pregnant women with diabetes take metformin during pregnancy

Yariv Yogev – CON

Denice Feig – PRO

SatishGargUSAManaging T1D-new-onsets and DKA through telehealth
MichaelHallerUSAUsing tele-education with the ECHO model to reach primary care providers in rural areas to improve the level of care for people with diabetes
IrlHirschUSA·        Lessons learned from the COVID-19 pandemic

·        How should reimbursement look after the COVID-19 pandemic

KoreyHoodUSALeveraging telehealth and digital tools to optimize use of diabetes devices
RomanHovorkaUKUse of the CamAPS FX closed-loop in the research and clinical investigation
BorisKovatchevUSAResults of a study on Closed-Loop Control (CLC) system – Control IQ
LoriLaffelUSA·        Patient preferences for automatic insulin delivery

·        Telemedicine for routine follow up type 1 diabetes pediatric visits

RobertLindsayUKFactors associated with stillbirth in women with diabetes
DavidMaahsUSANIH funded study: Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
LaurelMesserUSAArtificial pancreas device upgrades—best practices for onboarding and follow-up
HelenMurphyUKPregnancy outcomes of 17,375 women with diabetes: National population-based cohort study
StevenNissenUSADual or triple GLP/GIPs as treatment for T2D
SusanaPattonUSAIntervening on Hypoglycemia Fear in Parents of Young Children using Direct-to-Home Video-based Telehealth
WalterPoriesUSAToxic Intestinal signals as a cause of type 2 diabetes and the metabolic syndrome
EricRenardFranceEfficacy of Closed-loop Insulin Therapy in Adults Prone to Hypoglycemia – the International Diabetes Closed-Loop Trial Protocol 2
MichaelRiddellCanadaMonitoring the elite athlete with type 1
FrancescoRubinoUKAn international register for new onset diabetes during COVID-19 pandemic
AndreaScaramuzzaItalyBenefits and challenges of diabetes technology in children
DesmondSchatzUSALessons from the nPOD
JaySkylerUSA·        Diabetes Cardiovascular Outcome Trials – Current Status

·        Immunotherapy for type1 diabetes – Where are we now?

AmirTiroshIsraelVirtual Diabetes Clinic – the Dietitian Perspective
StuartWeinzimerUSADebate: In the era of remote visits – do we still need A1c measures

Fergus Cameron – PRO

Stuart Weinzimer – CON

YarivYogevIsraelDEBATE: Should all pregnant women with diabetes take metformin during pregnancy

CON – Yariv Yogev

PRO – Denice Feig